New Technology Breaks Through Cancer Pain
Below is a MRR and PLR article in category Health Fitness -> subcategory Disease Illness.
New Technology Offers Relief for Cancer PainSummary:
Cancer patients experiencing severe pain flare-ups may soon find relief with a new, user-friendly oral adhesive disc.
Article:
Cancer patients struggling with painful flare-ups, known as breakthrough pain, may soon benefit from an innovative, easy-to-use oral adhesive disc.
Cancer pain typically falls into two categories: persistent and breakthrough. Persistent pain is continuous and long-lasting, while breakthrough pain is sudden and intense, even for those already on medication for persistent pain. The American Cancer Society notes that many patients with persistent pain also experience breakthrough episodes, which can be triggered by activities like walking or dressing, or can occur unexpectedly. These episodes may result from the cancer itself or its treatment and are termed "breakthrough" because they disrupt a regular pain management routine.
Fast-acting medications that quickly exit the body are the best treatments for these flare-ups. These medications are taken "as needed" at the onset of breakthrough pain. One such medication is the opiate fentanyl.
BioDelivery Sciences has developed the next generation of fentanyl as a small, patient-friendly oral adhesive disc called BEMA™ Fentanyl. This disc consists of an adhesive layer and a nonadhesive backing layer, both capable of carrying the medication. It adheres to the inner cheek, delivering the medication directly. Remarkably, the BEMA™ disc disintegrates completely in the mouth, leaving no residue. This innovative solution is currently in Phase III clinical trials.
A crossover study comparing BEMA™ Fentanyl to Actiq, the leading lozenge form of fentanyl for breakthrough cancer pain, revealed that BEMA™ Fentanyl offers faster absorption and a higher concentration of the drug.
"Our study showed that the BEMA™ technology delivers fentanyl more efficiently and effortlessly," said BioDelivery CEO Mark Sirgo. "In addition to improved absorption, the BEMA™ disc was simpler to use, taking only seconds to apply."
According to the World Health Organization, pain is a significant issue for cancer patients, affecting up to 50% of those undergoing active treatment and up to 90% of those with advanced disease.
You can find the original non-AI version of this article here: New Technology Breaks Through Cancer Pain.
You can browse and read all the articles for free. If you want to use them and get PLR and MRR rights, you need to buy the pack. Learn more about this pack of over 100 000 MRR and PLR articles.